NO20071826L - 1,5-diheterosykel-1H-triazolderivat - Google Patents

1,5-diheterosykel-1H-triazolderivat

Info

Publication number
NO20071826L
NO20071826L NO20071826A NO20071826A NO20071826L NO 20071826 L NO20071826 L NO 20071826L NO 20071826 A NO20071826 A NO 20071826A NO 20071826 A NO20071826 A NO 20071826A NO 20071826 L NO20071826 L NO 20071826L
Authority
NO
Norway
Prior art keywords
diheterosykel
triazole
salt
cox
compound
Prior art date
Application number
NO20071826A
Other languages
English (en)
Inventor
Naoaki Kanaya
Kunihiko Fujii
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20071826L publication Critical patent/NO20071826L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives en forbindelse representert ved Formel (I): hvor Ar1, Ar2, R1 og R2 hver representerer en substituent, et salt derav, eller et solvat av forbindelsen eller saltet og til en medisin inneholdende samme. Ifølge foreliggende oppfinnelse er det tilveiebrakt et kraftig blodplateaggregeringsundertrykkende middel som ikke hemmer COX-1 og COX-2.
NO20071826A 2004-10-19 2007-04-10 1,5-diheterosykel-1H-triazolderivat NO20071826L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004303851 2004-10-19
PCT/JP2005/019207 WO2006043594A1 (ja) 2004-10-19 2005-10-19 １，５－ジ複素環－１ｈ－トリアゾール誘導体

Publications (1)

Publication Number Publication Date
NO20071826L true NO20071826L (no) 2007-06-14

Family

ID=36203009

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071826A NO20071826L (no) 2004-10-19 2007-04-10 1,5-diheterosykel-1H-triazolderivat

Country Status (13)

Country Link
US (1) US20080125409A1 (no)
EP (1) EP1803719A4 (no)
JP (1) JPWO2006043594A1 (no)
KR (1) KR20070063530A (no)
CN (1) CN101039934A (no)
AU (1) AU2005296582A1 (no)
CA (1) CA2583153A1 (no)
IL (1) IL182538A0 (no)
MX (1) MX2007004643A (no)
NO (1) NO20071826L (no)
RU (1) RU2007118659A (no)
WO (1) WO2006043594A1 (no)
ZA (1) ZA200703562B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060189591A1 (en) * 2003-04-21 2006-08-24 Daiichi Pharmaceutical Co., Ltd. Five-membered heterocyclic derivative
WO2015188073A1 (en) 2014-06-06 2015-12-10 Research Triangle Institute Apelin receptor (apj) agonists and uses thereof
RU2021133849A (ru) 2015-12-09 2022-03-21 Рисерч Трайэнгл Инститьют Улучшенные агонисты апелинового рецептора (apj) и их использование
MA46540A (fr) * 2016-10-12 2019-08-21 Res Triangle Inst Agonistes du récepteur de l'apéline (apj) hétérocyclique et leurs utilisations
US20230416229A1 (en) * 2020-11-05 2023-12-28 Bayer Aktiengesellschaft [(1,5-diheteroaryl-1h-1,2,4-triazol-3-yl)oxy] acetic acid derivatives as safeners for the protection of useful plants and crop plants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR878201A0 (en) * 2001-11-09 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. New compounds
WO2004060367A1 (en) * 2002-12-30 2004-07-22 Fujisawa Pharmaceutical Co., Ltd. Imidazole and triazole derivatives useful as selective cox-1 inhibitors
CA2515119A1 (en) * 2003-02-07 2004-08-19 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivative
US20060189591A1 (en) * 2003-04-21 2006-08-24 Daiichi Pharmaceutical Co., Ltd. Five-membered heterocyclic derivative

Also Published As

Publication number Publication date
AU2005296582A1 (en) 2006-04-27
IL182538A0 (en) 2007-09-20
RU2007118659A (ru) 2008-11-27
EP1803719A4 (en) 2008-07-02
CA2583153A1 (en) 2006-04-27
MX2007004643A (es) 2007-06-08
ZA200703562B (en) 2008-08-27
CN101039934A (zh) 2007-09-19
EP1803719A1 (en) 2007-07-04
JPWO2006043594A1 (ja) 2008-05-22
US20080125409A1 (en) 2008-05-29
WO2006043594A1 (ja) 2006-04-27
KR20070063530A (ko) 2007-06-19

Similar Documents

Publication Publication Date Title
TW200505447A (en) Pyrazole derivative
MA29549B1 (fr) Arylpyrazoles substitues destines a etre utilises contre des parasites
NO20063449L (no) Substituerte heterocykler og deres anvendelse
NO20060426L (no) Kannabinoid reseptormodulator
NO20061793L (no) 1,4-disubstituerte isoquinilonderlvater som RAF-kinaseinhibitorer nyttige for behandling av proliferative sykdommer
NO20071901L (no) Substituerte bisykliske imidazo-3-ylamin sammensetninger
EA200401613A1 (ru) Лекарственное средство для лечения рака
BRPI0508632A (pt) derivados de n1 ((pirazol-1-ilmetil)-2-metilfenil)-ftalamida e compostos inseticidas relacionados
NO20054854L (no) Femrings heterocykliske derivater
NO20074583L (no) Substiverte bis aryl- og heteroarylforbindelser som selektive 5HT2A antaconister
NO20054083L (no) Nye sammenkoblede triazoloner og deres anvendelse
NO20050921L (no) Nye fysiologisk aktive substanser
NO20063621L (no) Derivater av N-`(1,5-difenyl-1H-pyrazol-3-yl) sulfonamid med CB1 receptoraffinitet
NO20074718L (no) BCRP/ABCG2 inhibitor
NO20071826L (no) 1,5-diheterosykel-1H-triazolderivat
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
NO20070564L (no) Kinoliner uten tiazolinonsubstituenter.
ATE311367T1 (de) 5-substituierte alkylaminopyrazol-derivative als pestizide
NO20060718L (no) Substituerte tiofoner og deres anvendelse
NO20061045L (no) Imidazolderivater
NO20075080L (no) Pyridylmetylsulfonderivater
NO20081587L (no) Aerosolformulering for inhalering
NO20073710L (no) Kjemiske forbindelser
ATE425141T1 (de) Neue heteroarylsubstituierte acetonderivate als hemmstoffe der phospholipase a sb 2 /sb

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application